Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyEvaluation, Staging, and Monitoring of Chronic Hepatitis C
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
Sign In or Register to get started
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 4 Overview
Evaluation and Staging of Liver Fibrosis - 0%Topic 1
BackgroundActivities- 0%Topic 2
Indirect Markers for Estimating Hepatic FibrosisActivities- 0%Topic 3
Direct Markers of FibrosisActivities- 0%Topic 4
Radiologic Modalities to Estimate FibrosisEvaluation and Staging of Liver Fibrosis Overview
About this Lesson
Last Updated: March 16th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2013CNE and CME Review: April 11th, 2024CNE and CME Expiration: April 10th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Evaluation and Staging of Liver Fibrosis and available until April 11th, 2024.Learning Objectives
- Discuss noninvasive indirect markers used for estimating liver fibrosis
- Describe noninvasive direct markers used for estimating liver fibrosis
- Summarize key radiologic methods that can estimate hepatic fibrosis
- List the transient elastography cutoff that is used to estimate cirrhosis in persons with chronic HCV
- Explain the indications, risks, and histologic assessment for liver biopsy in persons with chronic HCV
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneMaria A. Corcorran, MD, MPHMaria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624